Elena M. Baldissera - Publications

Real-world efficacy and retention of guselkumab in psoriatic arthritis: insights from a 12-month multicenter study.

Journal: ARP rheumatology

Published: October 01, 2025

Clinical significance of endolymphatic hydrops on MRI in Cogan's syndrome: a case series of five patients.

Journal: European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery

Published: November 21, 2024

Effectiveness of intravenous infliximab versus subcutaneous adalimumab in Takayasu arteritis: a multicentre retrospective study.

Journal: Rheumatology (Oxford, England)

Published: October 28, 2024

Retention rates of different Janus kinase inhibitors in rheumatoid arthritis: experience from a large monocentric cohort.

Journal: Scandinavian journal of rheumatology

Published: June 04, 2024

Secukinumab is not associated with cancer recurrence or progression in patients with spondyloarthritis and history of neoplastic disease.

Journal: Rheumatology international

Published: December 28, 2023

Effectiveness and safety of rituximab in Takayasu arteritis: a multicenter retrospective study.

Journal: Joint bone spine

Published: August 29, 2023

Autoantibody-Mediated Depletion of IL-1RA in Still's Disease and Potential Impact of IL-1 Targeting Therapies.

Journal: Journal of clinical immunology

Published: August 17, 2023

The impact of 2023 EMA recommendations on patients treated with JAK inhibitors: real-life experience from a prospective monocentric cohort.

Journal: Rheumatology (Oxford, England)

Published: July 22, 2023

Histone-Specific CD4+ T Cell Plasticity in Active and Quiescent Systemic Lupus Erythematosus.

Journal: Arthritis & rheumatology (Hoboken, N.J.)

Published: March 23, 2023

Validation of the 2022 American College of Rheumatology/EULAR classification criteria for Takayasu arteritis.

Journal: Rheumatology (Oxford, England)

Published: February 01, 2023

Effectiveness of a two-year tapered course of tocilizumab in patients with giant cell arteritis: A single-centre prospective study.

Journal: Seminars in arthritis and rheumatism

Published: November 13, 2022

Intravenous versus subcutaneous tocilizumab in Takayasu arteritis: multicentre retrospective study.

Journal: RMD open

Published: October 30, 2022